Abstract
NO. Insulin glargine may lead to less patient-reported, symptomatic, and nocturnal hypoglycemia, although overall, there may not be a difference in the risk for severe hypoglycemia orhypoglycemiarelated emergency department (ED) visits and hospitalizations (strength of recommendation [SOR]: B, systematic review of randomized controlled trials [RCTs], individual RCTs, and observational study).
Original language | American English |
---|---|
Journal | Journal of Family Practice |
DOIs | |
Status | Published - May 1 2021 |
Keywords
- Adult
- Aged
- 80 and over
- Diabetes Mellitus
- Type 2
- Female
- Humans
- Hypoglycemia
- Insulin Glargine
- Insulin
- Isophane
- Male
- Middle Aged
- Treatment Outcome